Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

RNA-loaded dendritic cell vaccine shows promise combined with sunitinib

Feb. 8, 2012

Study compares apixaban to warfarin in subgroup of ARISTOTLE participants

Feb. 7, 2012

Temsirolimus shows limited activity in refractory metastatic urothelial cancer

Feb. 7, 2012

Pilot study assesses veliparib/temozolomide combination in metastatic CRPC

Feb. 7, 2012

Phase II trial assesses RO-4929097 in prostate cancer

Feb. 6, 2012

OGX-427 shows signs of efficacy in phase II trial

Feb. 6, 2012

Cixutumumab and ramucirumab studied in metastatic castration-resistant prostate cancer

Feb. 6, 2012

Rilotumumab does not improve efficacy of combination therapy in prostate cancer trial

Feb. 6, 2012

VT-464 reduces tumor growth in prostate cancer model

Feb. 3, 2012

ARN-509 is well tolerated in phase I/II study

Feb. 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026